Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials
K. Reich, A. M. DeLozier, F. P. Nunes, J. P. Thyssen, L. F. Eichenfield, A. Wollenberg, J. A. Ross Terres, S. D. Watts, Y. F. Chen, E. L. Simpson, J. I. Silverberg*
Dyk ned i forskningsemnerne om 'Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials'. Sammen danner de et unikt fingeraftryk.